3D-QSAR and Its Emerging Role in Modern Medicinal Chemistry

Quantitative structure–activity relationship (QSAR) models are essential computational tools in modern drug discovery, enabling the prediction of biological activity based on the structural features of chemical compounds. While traditional 2D-QSAR methods rely on physicochemical and topological descriptors, they lack spatial information and therefore cannot accurately represent the three-dimensional nature of ligand–receptor interactions. To address these limitations, three-dimensional QSAR (3D-QSAR) approaches such as Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) were developed. These methods analyze steric, electrostatic, hydrophobic, and hydrogen-bonding fields around aligned molecular structures, offering more realistic insights into the molecular determinants of biological activity. 3D-QSAR generates contour maps that visually guide medicinal chemists during lead optimization by indicating favorable and unfavorable regions for structural modification. The integration of 3D-QSAR with molecular docking, pharmacophore modeling, and machine learning techniques has further enhanced its accuracy and applicability, even in cases where receptor structures are unavailable. Despite challenges such as alignment dependency and conformational variability, 3D-QSAR remains a powerful tool for rational drug design, ADMET prediction, and receptor-subtype selectivity. With advancements in artificial intelligence and computational power, 3D-QSAR continues to evolve as a cornerstone of modern medicinal chemistry.